anti-Enrofloxacin antibody product blog
Tags: Antibody; Monoclonal Antibody; Enrofloxacin; anti-Enrofloxacin antibody;
The Enrofloxacin n/a (Catalog #MBS190032) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Enrofloxacin can be used in a range of immunoassay formats including, but not limited to, ELISA.ELISA: Endpoint titer for ascites is 1:1,000-1:2,000 with enrofloxacin or ciprofloxacin on the solid phase at 0.5- 1.25 ug/well. Not all applications have been investigated. Researchers should empirically determine the suitability of the Enrofloxacin n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Enrofloxacin is a fluoroquinolone that inhibits the activity of bacterial DNA gyrase. It was the first fluoroquinolone antimicrobial to be used in veterinary medicine and is indicated in therapy of infections by E. coli, Salmonella, Pasteurella, Mycoplasma and Hemophilus species. In the USA, approved use is currently limited to dogs, but approval for use in foodanimals is under consideration.
Antigen: Enrofloxacin conjugated to KLH (keyhole limpet hemocyanin) via carbodiimide. Stabilizer: None
Preservatives: None. Available on request.
Dilutions Instructions: Dilute in PBS or medium which is identical to that used in the assay system. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Enrofloxacin are readily searchable from our website. Different antibodies against the same target such as Enrofloxacin may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.